PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that it has appointed David W. Froesel, Jr. as Executive Vice President, Chief Financial Officer and Treasurer. Mr. Froesel has served as PharMerica's interim Chief Financial Officer since April, 2013.
Gregory S. Weishar, PharMerica Corporation’s Chief Executive Officer, said, “After a thorough search process, we are pleased to announce that David Froesel has been selected as the Company’s Chief Financial Officer. David has a proven track record in our industry and has done a great job as Interim CFO. He is uniquely suited to serve as PharMerica’s Chief Financial Officer.”
“I am honored to be a part of the PharMerica team,” said David Froesel. “I am excited about the Company’s long-term prospects and believe we will successfully execute our business strategies and continue to broaden the Company’s business lines. I have been impressed by the Company’s dedication to delivering outstanding customer service and product offerings. PharMerica has a great team of more than 6,100 employees who are dedicated to improving the lives of patients in the institutional and home settings through the use of innovative and dependable pharmaceutical services.”
About David W. Froesel, Jr.Mr. Froesel, age 61, was Senior Vice President and Chief Financial Officer of Omnicare, Inc., from 1996 to 2009. Prior to that, he was Vice President, Finance & Administration and Corporate Controller of subsidiaries of Mallinckrodt Group, Inc., a $2.5 billion healthcare and specialty chemical company. He received a B.S. in Accounting from the University of Missouri-St. Louis and an M.S. in Accounting from St. Louis University, and he is a Certified Public Accountant. About PharMerica PharMerica Corporation is a leading institutional pharmacy services company that services healthcare facilities in the United States, provides pharmacy management services to hospitals, and also provides specialty infusion services to patients outside a hospital setting. As of June 30, 2013, PharMerica operated 90 institutional pharmacies and 12 specialty infusion centers in 45 states. PharMerica’s customers are institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, individuals receiving in-home care and other long-term alternative care providers.